Nektar Therapeutics
NKTR
NKTR
342 hedge funds and large institutions have $5.41B invested in Nektar Therapeutics in 2018 Q4 according to their latest regulatory filings, with 50 funds opening new positions, 138 increasing their positions, 122 reducing their positions, and 91 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less funds holding
Funds holding: →
44% less capital invested
Capital invested by funds: $9.73B → $5.41B (-$4.32B)
45% less first-time investments, than exits
New positions opened: 50 | Existing positions closed: 91
50% less funds holding in top 10
Funds holding in top 10: 6 → 3 (-3)
Holders
342
Holding in Top 10
3
Calls
$89.9M
Puts
$50.5M
Top Buyers
| 1 | +$174M | |
| 2 | +$99.9M | |
| 3 | +$67.1M | |
| 4 |
AQR Capital Management
Greenwich,
Connecticut
|
+$24M |
| 5 |
D.E. Shaw & Co
New York
|
+$20.6M |
Top Sellers
| 1 | -$67.8M | |
| 2 | -$66M | |
| 3 | -$51.7M | |
| 4 |
Capital Fund Management (CFM)
Paris,
France
|
-$43.1M |
| 5 |
SI
Scout Investments
Kansas City,
Missouri
|
-$28.9M |